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Abstract 
Background: Migraine consisting of migraine with aura (MA) and migraine without aura (MO) is a painful 
neurovascular disorder affecting approximately 16% of the general population. A combination of genetic and 
environmental factors is involved in the pathogenesis of migraine. The MTHFR enzyme is involved in homocysteine 
(Hcy) metabolism and it has been reported that 1298 A to C and 677 C to T mutations   in the MTHFR gene are 
associated with an increased in plasma Hcy levels. Hcy is a highly reactive amino acid and causes endothelial injury. 
Because a plausible theory about vascular impairment in migraine, it is considered that mutations in MTHFR gene 
and folate metabolism are associated with migraine. Materials and Methods: In total, 75 patients with migraine 
(24 with MA and 51with MO) in accordance with the IHS criteria participated in this case-control study. Control 
group were 128 normal matched healthy subjecys who selected from same region without history of migraine or 
other neurologic disorder after interviewing and examining by a physician. Mean age at entry was 36.42±9.6 and 
31.64±8.9 years old in migraine and control group respectively.  MTHFR polymorphisms were investigated by PCR-
RFLP. Results: Genotypic results indicated that the prevalence of the MTHFR 677TT genotype in migraine 
subjects was higher than control (17.3% and 3.1% respectively, P<0.001).  Interestingly the risk of migraine was 
6-fold higher in subjects possessing the MTHFR 677T homozygous variant (OR=6.5; CI95%: 2.03-20.76). No 
significant difference in the prevalence of MTHFR A1298C genotypes was observed in migraine group when 
compared to controls (P>0.001). Conclusion: It seems that MTHFR C677T is a potential genetic risk factor for 
migraine attacks, both in MA and MO subclasses in Iranian population. C677T and A1298C joint effect could 
amplify the potential influence of each SNPs. 
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Introduction
Migraine disorder is a common debilitating 
neurovascular disorder affecting approximately 16% 
of the population and is more frequent in women 
[1]. Unilateral headache, nausea, vomiting, photo- 
and phonophobia are the main features of disease 
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[1]. Common migraine ,migraine without aura (MO) 
and migraine with aura (MA) are two main 
subclasses of the disease and up to one-third of 
patients experience an aura prior or during the 
headache attacks [2].  
Migraine is a complex disorder and both 
genetic susceptibility and environmental triggers 
could play a role in the pathogenesis of disease. 
Many genes has been considered  as predisposing 
factors in initiating  migraine attacks mainly in MA 
than in MO [1-3]. Several studies have indicated 
various susceptibility genes for common migraine 
including MTHFR and some other genes [2, 4, 5]. 
The MTHFR gene  , located on chromosome 
1 (1p36.3), is composed of 11 exons and 10 introns. 
MTHFR catalyzes the biosynthesis of 5-
methyltetrahydrofolate and used for homocysteine 
remethylation to methionine. It has been 
demonstrated that hemocysteine could inhibit DNA-
methyltransferase and causes DNA 
hypomethylation.Therefore, impaired enzyme 
activity of MTHFR was associated with 
dysregulation of folate metabolism [6, 7]. Among 
polymorphisms in  MTHFR gene,  the  C677T and 
A1298C   substitution have been investigated so far. 
The substitution of alanine for valine in the MTHFR 
protein resulted from  C677T  polymorphism which 
is located within the catalytic domain of the enzyme.  
In this regard, the presence of T allele was 
associated with decrease in enzyme activity, thereby 
alteration in circulating levels of  homocysteine and 
folate metabolites. 
Similarly, Polymorphism A1298C affects the 
enzyme activity of MTHFR as well as folate 
concentrations, although less than those in C677T. 
Additionally, this polymorphism is located within 
the regulatory domain. Hence, the investigation of 
MTHFR  polymorphism  and its effect on metabolic 
pathway of   folate  has been considered as an 
interesting issue in recent years [8]. 
Considering involvement of vascular 
mechanisms in migraine pathogenesis, 
polymorphisms in methylenetetrahydrofolate 
reductase (MTHFR) gene appear to act as an 
interfering factor in folate metabolism and cause 
elevation in plasma homocysteine (Hcy) level [9] 
and ultimately endothelial injury [10, 11]. This 
could be in favor of the role of vascular malfunction 
in migraine etiology [6, 10].  
Here we aimed to investigate the relationship 
between two MTHFR gene SNPs (rs1801133; 
C677T and rs1801131; A1298C) with susceptibility 
to migraine in Iranian patients with migraine attacks. 
Methods
Patients were selected from those who referred 
to Neurology Clinics, Imam Khomeini, Rasoul Akram 
Hospitals and Aramesh Migraine Clinic, Tehran, Iran 
based on international headache society (HIS) criteria 
[12]. A complete demographic and medical history 
questionnaire was obtained from all cases. A brief 
neurologic examination was performed for each case. 
Healthy controls were selected from those without 
history of migraine or other neurologic disorder after 
interviewing and examining by a physician.  
Venous blood sample was collected from all 
participant and genomic DNA was extracted from 
EDTA-treated whole-blood samples from white blood 
cells using salting out method [13]. Informed consent 
was obtained from all participants prior to the study. 
The project was approved by the Ethics Committee of 
Tehran University of Medical Sciences. 
C677T and A1298C polymorphisms were 
analyzed by PCR-RFLP (Restriction Fragment 
Length Polymorphism) methods using  primers (Table 
1) obtained from previous studies with minor
modification [14]. PCR amplification was performed 
in a final volume of 25 µl containing 2.5 µl 10X PCR 
buffer, 0.8 μl of 50mM Mgcl2, 0.5μl of each 10pmol 
forward and reverse primer, 0.6μl of 10mM dNTPs, 
3μl of DNA template and 0.5μl of 5u/μl Tag DNA 
polymerase. Thermal cycling was performed in 
Eppendorf master cycler (Germany) with an initial 
denaturation of 3 min at 95°C, then 34 cycles of 
denaturation at 94°C for 55 seconds, annealing at 
56°C for 45 seconds, and extension at 72°C for 50 
seconds followed by a final extension at 72°C for 10 
min. Amplified DNA were visualized and approved 
using gel electrophoresis on agarose 1% and staining. 
PCR products were digested by HinfI and 
MboII restriction enzymes to identify specific alleles 
in C677T and A1298C polymorphisms respectively. 
The digestion reaction for each PCR product was 
carried out in a final volume of 15µL containing 1µL 
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buffer, 0.2µL restriction enzyme and 10µL PCR 
product. Then it was incubated at 37°C overnight. 
Digested products were visualized on 2.5% agarose 
gel stained with ethidium bromide. 
C677T PCR product (198 bp) was digested into 
175 and 23 bp fragments by Hinf I for T-allele. 
A1298C PCR product (256 bp) was digested into 204, 
30 and 22 bp fragments by Mbo II for C-allele. DNA 
sequencing used to confirm PCR-RFLP results. 
Analysis was carried out using SPSS 13.0 and 
P<0.05 was considered significant. Hardy–Weinberg 
equilibrium was evaluated using PowerMarkerV.325. 
Genotype and allele frequencies were tested using χ2-
test. 
We used χ2-test for evaluating genotype and 
allale frequencies. The risk of migraine for mutant 
allele carriers was reported as odds ratios (OR) and 
95% confidence intervals between groups. 
Continuous variables were expressed as means ± SD 
and evaluated between groups by t-Test. 
Results
Seventy-five migraineurs (57 women and 18 
men) and 128 healthy people (85 women and 43 men) 
were recruited into the study after initial evaluation. 
Mean age at entry was 36.42±9.6 and 31.64±8.9 years 
old in migraine and control group respectively.  
A-allele and C-allele were more frequent in 
A1298C and C677T SNPs as was shown in Table 2 
and allele frequency of A1298C and C677T were in 
Hardy–Weinberg equilibrium among migraineurs and 
controls (P=0.74 and P=1.0, respectively). 
A significantly higher frequency of T667-allele 
was observed in the migraineurs group as compared 
to controls that was associated with an increased risk 
of migraine (OR=1.47; CI95%: 1.10-1.97). A non-
significantly higher frequency of C1298-allele was 
observed in the migraineurs group as compared to 
controls (Table 2). 
A significantly higher frequency of TT667 
genotype was observed in the migraineurs patient 
group as compared to controls (17.3% and 3.1% 
respectively, P< 0.001) (OR=6.5; CI95%: 2.03-20.76) 
and A1298C polymorphic genotype distribution did 
not show any statistically frequency difference among 
the migraineurs patient group as compared to controls 
(Table 3). 
Based on comparing migrane subclasses, MA 
and MO with healthy controls, 677TT genotype was 
related to both types but A1298C genotype was not 
associated with MA or MO (Table 4). 
When two MTHFR polymorphisms were 
analyzed simultaneously, allelic changes (677CT-
1298CC or 677CC-1298AC) were more frequent in 
the migraineurse group as compared to controls (20% 
and 3.9% respectively, P< 0.0001) (Table 5) and 
TT677/AC1298 genotype was also more frequent in 
patients than controls (P<0.01) (Table 6). 
Discussion
It has been suggested that MTHFR dysfunction 
Table 1: Primer sequence for C677T and A1298C 
polymorphism detection. 




5'-AGG ACG GTG CGG TGA GAG 
TG-3' 
C677T F 




A1298C R 5'-CATGTCCACAGCATGGAG-3' 
A1298C F 5'-CTTCTACCTGAAGAGCAAGTC-3' 
Table 2: Allele frequency of A1298C and C677T 



























* P<0.001, Odd ratio=1.47; CI95%:1.10-1.97
Table 3: Genotypic frequency of A1298C and C677T 
polymorphisms in case and control groups. 
Controls 
(%) 
Cases (%) Genotype Polymorphism 
66 (51.6) 31 (41.3) CC 
C677T 58 (45.3) 31 (41.3) CT 
4 (3.1)* 13 (17.3) TT 
44 (34.4) 25 (33.3) AA 
A1298C 63 (49.2) 36 (48.0) AC 
21 (16.4) 14 (18.7) CC 
* P<0.001, Odd ratio=6.5; CI95%:2.03-20.76
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could lead to a wide range of vascular and 
neurological diseases. Therefore, investigation of 
functional MTHFR polymorphisms in disorders with 
the vascular pathology is an interesting topic. 
Migraine is a common cause of headache 
disorder mostly in middle age women, affecting their 
productivity and health related quality of life. Its 
direct and indirect annual cost is more than 11 billion 
and 19.6 billion USD  in USA [15]. 
As familial aggregation of migraine 
strengthens the possible inherited pattern of disease 
[16-18], many investigations were conducted to find 
candidate genes involving in migraine 
pathophysiology. However, this familial aggregation 
seems to be influenced by different factors like 
environmental triggers, susceptibility genotypes, 
mode of inheritance and penetrance. Because of 
multi-factorial and multigenic property of migraine, 
many candidate genes like MTHFR, ESR1, PGR, 
INSR, ACE genes were introduced as role-players in 
migraine attacks mainly in MA [1-5] .These genes are 
mostly related to neural pathways and molecular 
mechanisms affecting endothelial function as main 
points in migraine pathophysiology [19]. 
Since candidate genes using case-control study 
is a powerful method and direct strategy for 
recognition of  low effect but predisposing genes for a 
disease [19], we compared MTHFR common 
polymorphisms in migraine patients with healthy 
individuals. Result showed that 677TT genotype in 
migraine patients is significantly more prevalent than 
normal people and also in both MO and MA 
subgroups than control group. These results are in 
compliance with some indicative findings about 
increase susceptibility to migraine and presence of 
677T allele [10, 19-22] particularly when homozygote 
form is present and in patient with migraine with urea 
[10, 19, 21-24].  
In this study, when A1298C genotype 
frequency in migraineurs was compared with healthy 
Table 4: Genotypic frequency of A1298C and C677T 




































21 (16.4) CC 
Table 6: Diplotype frequency from CT677/AC1298 





Patients (%) C677T/A1298C 
Diplotype 
















13 (17.3) CT/AC 
N.S 5 (3.9) 5  (6.7) CT/CC 
N.S 4 (3.1) 3 (4) TT/AA 
0 (0)* 10 (13.3) TT/AC 
0 (0) 0 (0) TT/CC 
Table 5: Frequency of allelic changes due to 
CT677/AC1298 polymorphisms in case and control 
groups.  
* P<0.0001.
Controls (%) Patients (%) A1298C C677T 
22 (17.3) 9 (12) AA CC 
44 (34.6) 26 (34.7) 
AC CC 
AA CT 




5 (3.9)* 15 (20.0) 
CC CT 
AC TT 
0 (0) 0 (0) CC TT 
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group, no significant discrepancy was found which 
was in conflict with other perusal observing positive 
relevance between migraines and both 1298AC and 
677TT genotypes. In contrast with our result, they 
also showed these alleles have higher genotype 
frequency in migraineurs in comparison with the 
control group [25, 26]. Different ethnicity and might 
be lower sample size particularly in MA subgroup 
might verified our opposite results. 
However an extremely higher frequency of 
genotypes with 3 changes in both polymorphisms 
(677CT+1298CC and 677TT+1298AC), were 
observed in patient group. Furthermore a more 
significant susceptibility to migraine was also showed 
in subjects with 677TT/1298AC diplotype in 
comparison with 677CT/1298CC subjects. 
Based on the fact that the C677T SNP takes 
places in the catalytic domain and the A1298C SNP 
occurs within the regulatory domain of the MTHFR 
enzyme, 677TT/1298CC genotype might cause quiet 
enzyme disability that could have lifelessness effect 
[25], as expected, subjects who had simultaneously 
homozygote form (677TT/1298CC) of two common 
MTHFR polymorphisms were not found in our study 
which was in agreement with other studies [25, 27]. 
In 2002 Kara’s group study it was found that 
individuals with 677CC/1298CC and 677TT/1298AA 
diplotype are more susceptible to migraine attacks in 
comparison with subjects who have normal genotype 
of enzyme (1298AA/677CC) [25].  
Finally while our study showed the positive 
and powerful effect of the simultaneous occurrence of 
two polymorphisms on decrease of MTHFR enzyme 
activity, some studies analyzed the effect of these 
polymorphisms on migraine together. Therefore, to 
get higher qualified data and better understanding 
about effects of MTHFR gene polymorphisms on 
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